Page 9 - Stagezero Life Sciences News Today

StageZero Life Sciences Offers Drive-Up, COVID-19 PCR Travel Testing with Results Reported the Same Day ACCESSWIRE 02 Jun 2021, 21:31 GMT+10 StageZeros Richmond, VA laboratory provides same-day test results and documentation required for travel to many international destinations RICHMOND, VA / ACCESSWIRE / June 2, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) (StageZero or the Company), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, toda...

StageZero Life Sciences Announces Q1 2021 Financial Results and Operational Update ACCESSWIRE Q1 Revenue of $2.5 Million TORONTO, ON / ACCESSWIRE / May 17, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) (StageZero or the Company), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced its first-quarter financial results for the three months ended March 31, 2021, and provided an update on its business progress. The Company generat...

StageZero Life Sciences Ltd: StageZero to Issue Q1 2021 Financial Results and Hold Conference Call on Monday, May 17 About StageZero Life Sciences, Ltd. StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Companys next-generation test, Aristotle®, is the first-ever multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZeros full service,...

StageZero Life Sciences Announces Rexall as Retailer for COVID-19 Saliva Test Kits Throughout Canada ACCESSWIRE 11 May 2021, 21:31 GMT+10 TORONTO, ON / ACCESSWIRE / May 11, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) (StageZero or the Company), a specialist in PCR testing dedicated to the early detection of multiple disease states through whole blood, today announced Rexall as the retail outlet that will distribute its COVID-19 PCR saliva test kits in British Columbia, Alberta, Saskatchewan...

(1) TORONTO, ON / ACCESSWIRE / May 11, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple disease states through whole blood, today announced Rexall as the retail outlet that will distribute its COVID-19 PCR saliva test kits in British Columbia, Alberta, Saskatchewan, Manitoba and Ontario beginning May 5. Rexall is a leading drugstore operator with more than 400 pharmacies across Canada. "Stage...

StageZero Life Sciences Ltd: StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute via its partner Ichor Blood Services through a Canadian retail outlet, COVID-19 PCR saliva test kits in British Columbia, Alberta, Saskatchew...

Press release content from Accesswire. The AP news staff was not involved in its creation. StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada May 5, 2021 GMT TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute ... TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sci...

(0) TORONTO, ON / ACCESSWIRE / April 19, 2021 / StageZero Life Sciences (TSX:SZLS), a company dedicated to early detection of multiple disease states through whole blood, today announced that it will be presenting at the Planet MicroCap Showcase: VIRTUAL on Thursday April 22 at 8:30 AM EST. James Howard-Tripp, Chairman and CEO of StageZero will be hosting the presentation and answering questions from investors. To access the live presentation, please use the following information: Planet MicroC...

Share this article Share this article ResearchAndMarkets.coms offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising fo...

StageZero Life Sciences Ltd: StageZero Life Sciences Announces Signed Letter of Intent for the Acquisition of Health Clinics Limited TORONTO, ON / ACCESSWIRE / April 1, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) (" StageZero" or the " Company") is pleased to announce that effective March 31, 2021 is has entered into a letter of intent to purchase substantially all of the business of Health Clinics Limited and of Health Clinics USA Corp. (together, the "HC Companies") related to their curren...